Esin Candemir

Esin Candemir

Auto-generated profile, based on publicly available information

Esin Candemir

University Hospital Frankfurt

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
ECEsin Candemir
Esin Candemir
LKLeonie Kollert
Leonie Kollert
LWLena Weißflog
Lena Weißflog
MGMaria Geis
Maria Geis
AMAntje Müller
Antje Müller
FFFlorian Freudenberg
Florian Freudenberg

27 August 2021 in EBioMedicine
Verified
Journal Article
Open access
FFFlorian Freudenberg
Florian Freudenberg
ECEsin Candemir
Esin Candemir
XCXufeng Chen
Xufeng Chen
LLLi-Li Li
Li-Li Li
DEDilhan Esen-Sehir
Dilhan Esen-Sehir
ARAndreas Reif
Andreas Reif
Nitric oxide synthase 1 adaptor protein (NOS1AP; previously named CAPON) is linked to the glutamatergic postsynaptic density through interaction with neuronal nitric oxide synthase (nNOS). NOS1AP and its interaction with nNOS have been associated with several mental disorders. Despite the high levels of NOS1AP expression in the hippocampus and the relevance of this brain region in glutamatergic signalling as well as mental disorders, a potential role of hippocampal NOS1AP in the pathophysiology of these disorders has not been investigated yet. To uncover the function of NOS1AP in hippocampus, we made use of recombinant adeno-associated viruses to overexpress murine full-length NOS1AP or the NOS1AP carboxyterminus in the hippocampus of mice. We investigated these mice for changes in gene expression, neuronal morphology, and relevant behavioural phenotypes. We found that hippocampal overexpression of NOS1AP markedly increased the interaction of nNOS with PSD-95, reduced dendritic spine density, and changed dendritic spine morphology at CA1 synapses. At the behavioural level, we observed an impairment in social memory and decreased spatial working memory capacity. Our data provide a mechanistic explanation for a highly selective and specific contribution of hippocampal NOS1AP and its interaction with the glutamatergic postsynaptic density to cross-disorder pathophysiology. Our findings allude to therapeutic relevance due to the druggability of this molecule. This study was funded in part by the DFG, the BMBF, the Academy of Finland, the NIH, the Japanese Society of Clinical Neuropsychopharmacology, the Ministry of Education of the Russian Federation, and the European Community.

1 September 2019 in Behavioural Brain Research
Verified
Journal Article
Closed access
ECEsin Candemir
Esin Candemir
APAntonia Post
Antonia Post
UDUlrich Severin Dischinger
Ulrich Severin Dischinger
RPRupert Palme
Rupert Palme
DSDavid A. Slattery
David A. Slattery
ARAndreas Reif
Andreas Reif

10 December 2022 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
ECEsin Candemir
Esin Candemir
NFNikolai Fattakhov
Nikolai Fattakhov
ALAet O. Leary
Aet O. Leary
DSDavid A. Slattery
David A. Slattery
MCMichael J. Courtney
Michael J. Courtney
FFFlorian Freudenberg
Florian Freudenberg


1 October 2014 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
FFF. Freudenberg
F. Freudenberg
LKL. Kollert
L. Kollert
ECE. Candemir
E. Candemir
TTT. Töpner
T. Töpner
MGM. Geis
M. Geis
ARAndreas Reif
Andreas Reif